Addex Partners with Viva Biotech to develop oral small molecule positive allosteric modulators (PAMs) of the adenosine A2 receptor (ADORA2) to treat inflammatory diseases

Addex Pharmaceuticals Ltd.

Switzerland / Small-Cap Biopharma (<$1 billion)

$54.3m on 03/16/2012 [market cap]

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Viva Biotech Ltd.

China / Tools, Services, and Manufacturing

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced